JP2018515566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018515566A5 JP2018515566A5 JP2017560675A JP2017560675A JP2018515566A5 JP 2018515566 A5 JP2018515566 A5 JP 2018515566A5 JP 2017560675 A JP2017560675 A JP 2017560675A JP 2017560675 A JP2017560675 A JP 2017560675A JP 2018515566 A5 JP2018515566 A5 JP 2018515566A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutical composition
- composition according
- drug substance
- lubricant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562165333P | 2015-05-22 | 2015-05-22 | |
| US62/165,333 | 2015-05-22 | ||
| PCT/IB2016/052943 WO2016189435A1 (en) | 2015-05-22 | 2016-05-19 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018515566A JP2018515566A (ja) | 2018-06-14 |
| JP2018515566A5 true JP2018515566A5 (https=) | 2019-06-20 |
Family
ID=56081526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560675A Pending JP2018515566A (ja) | 2015-05-22 | 2016-05-19 | 医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20180153899A1 (https=) |
| EP (1) | EP3297609A1 (https=) |
| JP (1) | JP2018515566A (https=) |
| KR (1) | KR20180008511A (https=) |
| CN (1) | CN107847448A (https=) |
| AU (1) | AU2016268477B2 (https=) |
| BR (1) | BR112017024337A2 (https=) |
| CA (1) | CA2986522A1 (https=) |
| CL (1) | CL2017002948A1 (https=) |
| HK (1) | HK1245073A1 (https=) |
| IL (1) | IL255510A (https=) |
| MX (1) | MX2017014987A (https=) |
| PH (1) | PH12017502017A1 (https=) |
| RU (1) | RU2017145095A (https=) |
| WO (1) | WO2016189435A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110831582B (zh) * | 2017-07-05 | 2023-08-11 | 诺华股份有限公司 | 药物组合物 |
| KR20190089668A (ko) | 2018-01-23 | 2019-07-31 | 현대모비스 주식회사 | 브레이크 장치용 패드 라이너 |
| KR20200043618A (ko) * | 2018-10-18 | 2020-04-28 | 주식회사유한양행 | 아미노피리미딘 유도체 또는 이의 염을 포함하는 경구투여용 약학 조성물 |
| CN115974803B (zh) * | 2022-12-12 | 2024-04-09 | 渐宽(苏州)生物科技有限公司 | 一种普赛莫德的晶型及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3782612B1 (en) * | 2008-05-15 | 2023-11-08 | Celgene Corporation | Oral formulations of cytidine analogs and methods of use thereof |
| WO2010147768A1 (en) * | 2009-06-15 | 2010-12-23 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone |
| UY33472A (es) * | 2010-06-30 | 2012-01-31 | Novartis Ag | ?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?. |
| JO3300B1 (ar) * | 2012-06-06 | 2018-09-16 | Novartis Ag | مركبات وتركيبات لتعديل نشاط egfr |
| US9675587B2 (en) * | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
-
2016
- 2016-05-19 EP EP16725242.8A patent/EP3297609A1/en not_active Withdrawn
- 2016-05-19 HK HK18104248.2A patent/HK1245073A1/zh unknown
- 2016-05-19 JP JP2017560675A patent/JP2018515566A/ja active Pending
- 2016-05-19 US US15/576,001 patent/US20180153899A1/en not_active Abandoned
- 2016-05-19 WO PCT/IB2016/052943 patent/WO2016189435A1/en not_active Ceased
- 2016-05-19 KR KR1020177033602A patent/KR20180008511A/ko not_active Withdrawn
- 2016-05-19 AU AU2016268477A patent/AU2016268477B2/en not_active Ceased
- 2016-05-19 CA CA2986522A patent/CA2986522A1/en not_active Abandoned
- 2016-05-19 CN CN201680043060.9A patent/CN107847448A/zh active Pending
- 2016-05-19 MX MX2017014987A patent/MX2017014987A/es unknown
- 2016-05-19 BR BR112017024337-7A patent/BR112017024337A2/pt not_active Application Discontinuation
- 2016-05-19 RU RU2017145095A patent/RU2017145095A/ru not_active Application Discontinuation
-
2017
- 2017-11-07 IL IL255510A patent/IL255510A/en unknown
- 2017-11-07 PH PH12017502017A patent/PH12017502017A1/en unknown
- 2017-11-21 CL CL2017002948A patent/CL2017002948A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| FI4088720T3 (fi) | Rimegepantti cgrp-liittyviin häiriöihin | |
| JP5911969B2 (ja) | 心臓血管障害の治療方法 | |
| JP2018515566A5 (https=) | ||
| US9629808B2 (en) | Sustained-release solid preparation for oral use | |
| TW201642864A (zh) | 利伯西利（ｒｉｂｏｃｉｃｌｉｂ）錠劑 | |
| JP2016516698A5 (https=) | ||
| JP2011503017A (ja) | ヒドロモルホン含有徐放性錠剤 | |
| JP2020525436A5 (https=) | ||
| CN111212641A (zh) | 阿普斯特的药物组合物 | |
| JP2016530238A5 (https=) | ||
| JP2017502948A5 (https=) | ||
| CN101500542A (zh) | 控释制剂 | |
| JP2017222645A (ja) | 腸溶性被覆顆粒の耐酸性が改善された圧縮成形錠剤 | |
| RU2017145095A (ru) | Фармацевтические композиции | |
| JP2021512869A5 (https=) | ||
| JP2015120758A5 (https=) | ||
| JP2017048174A (ja) | 化学的に安定な原薬含有被覆粒子を含む口腔内崩壊錠剤 | |
| JP2019518736A5 (https=) | ||
| WO2012123922A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| JP2017031117A (ja) | 光安定性を向上した、イミダフェナシン製剤 | |
| WO2015085739A1 (zh) | 一种多层固体药物剂型 | |
| JP6210640B2 (ja) | ホリナートカルシウム含有錠 | |
| JP2018516274A5 (https=) | ||
| TW202114658A (zh) | 達洛魯胺之醫藥組成物 |